- A new study suggests the blood vessels inside fat tissue do more than respond to obesity and type 2 diabetes – they may actively help drive the disease process.
- Researchers found clear changes in vascular cells in people with obesity and type 2 diabetes, including signs linked to inflammation and tissue damage.
- The findings are early, but they raise the possibility that blood vessels in fat tissue could become a future treatment target.
Fat tissue is often treated as little more than stored energy.
In reality, it is a highly active tissue that constantly communicates with the rest of the body.
That communication depends in part on a dense network of blood vessels.
A new study in Nature Metabolism suggests those blood vessels may be more important in metabolic disease than many people assumed.
Researchers analysed nearly 70,000 vascular cells from fat tissue taken from 65 people.
Using single-cell methods, they built a detailed map of the different endothelial cells that line blood vessels in human fat tissue.
They found far more diversity than expected.
Different vascular cell types appeared to have different specialised roles.
When the team compared healthy tissue with tissue from people with obesity and type 2 diabetes, they found clear differences.
In disease states, the vascular cells had shifted towards patterns linked to inflammation and tissue injury.
That matters because those are two of the main processes involved in metabolic disease.
In other words, the blood vessels may not just be reacting to a bad environment.
They may be helping shape it.
The researchers also identified a previously unrecognised group of cells with mixed features.
These cells seemed to share traits seen in vascular, connective tissue, fat and immune cells.
- Belly fat plus low muscle mass linked to higher death risk
- New diabetes pill could burn fat without harming appetite
- How visceral fat may trigger type 2 diabetes
That suggests more cellular flexibility than expected, which may also matter for how disease develops.
This is still early stage biology rather than a new treatment.
But it points to something important.
If fat tissue blood vessels help drive metabolic dysfunction, then future therapies may need to look beyond hormones and glucose alone.
